Did David Perdue buy AbbVie stock?

Common questions

Did David Perdue buy AbbVie stock?

Yes. David Perdue disclosed 1 purchase and 1 sale of AbbVie (ABBV) stock between Jan 7, 2016 and Jul 15, 2019, in STOCK Act reports. Added together, the disclosed purchases come to $1K-$15K and the disclosed sales to $15K-$50K.

How big were David Perdue's AbbVie trades?

STOCK Act reports give a range for each trade, such as $15K-$50K, never an exact amount. Added together, the disclosed purchases come to $1K-$15K and the disclosed sales to $15K-$50K.

Did David Perdue make these AbbVie trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does David Perdue still own AbbVie stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did David Perdue report these trades?

The latest filing is dated Aug 5, 2019. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Secretary of the Senate. Every trade links to the original filing.